- ANAC has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $13.2 million.
- ANAC has traded 200 shares today.
- ANAC is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in ANAC with the Ticky from Trade-Ideas. See the FREE profile for ANAC NOW at Trade-Ideas More details on ANAC: Anacor Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. ANAC has a PE ratio of 12.6. Currently there are 2 analysts that rate Anacor Pharmaceuticals a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Anacor Pharmaceuticals has been 495,700 shares per day over the past 30 days. Anacor has a market cap of $947.4 million and is part of the health care sector and drugs industry. The stock has a beta of 1.39 and a short float of 11.1% with 12.42 days to cover. Shares are up 35% year-to-date as of the close of trading on Thursday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.